Hillary Clinton has made reducing out-of-pocket drug costs and stopping pharmaceutical industry abuse a staple of her campaign presidency. A new ad is rolling through New Hampshire and Iowa that has Clinton criticizing the dramatic increase in the drug Daraprim. The ad launched right after the drug’s producer was purchased by a hedge fund manager
Pozen will buy Canada’s Tribute Pharmaceuticals for US$146 million, reports indicate. The US-based specialty drug manufacturer Pozen announced on Monday, June 8 that it has reached an agreement with the Canadian-based Tribute Pharmaceuticals in a deal that could cost Pozan about US$146 million. This is a big move for Pozen and one that is expected
The pharmaceutical industry is preparing to experience some major changes within the coming weeks. Zarxio is a drug that reduces infections caused by chemotherapy, and it is about to be the very first biosimilar drug to be sold in the United States. This drug is destined to revolutionize the U.S. pharmaceutical industry. A biologic medical
